Paper368262
The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
Dinarello CA and 3 others. J Infect Dis, 1978. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. Papers, record 368262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/368262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylmuramyl-Alanyl-Isoglutamine | Major topic |
| Adjuvants, Immunologic | Major topic |
| Glycopeptides | Major topic |
| Pyrogens | Major topic |
| Animals | |
| Endotoxins | |
| Escherichia coli | |
| Humans | |
| In Vitro Techniques | |
| Limulus Test | |
| Neutrophils | |
| Phagocytes | |
| Rabbits | |
| Staphylococcus | |
| Stimulation, Chemical |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42347646 | Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347646 | PubMed |
| 41528771 | Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/41528771 | PubMed |
| 39344184 | Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists. | J Med Chem | 2024 | https://conductscience.org/library/papers/39344184 | PubMed |
| 38393912 | Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38393912 | PubMed |
| 36237313 | Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency. | Front Oncol | 2022 | https://conductscience.org/library/papers/36237313 | PubMed |
| 34043358 | Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity. | J Med Chem | 2021 | https://conductscience.org/library/papers/34043358 | PubMed |
| 33585281 | Activity of Tracheal Cytotoxin of Bordetella pertussis in a Human Tracheobronchial 3D Tissue Model. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33585281 | PubMed |
| 31798878 | Translation of peptidoglycan metabolites into immunotherapeutics. | Clin Transl Immunology | 2019 | https://conductscience.org/library/papers/31798878 | PubMed |
| 16148175 | Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats. | Clin Diagn Lab Immunol | 2005 | https://conductscience.org/library/papers/16148175 | PubMed |
| 8751911 | Tolerance to appetite suppression induced by peptidoglycan. | Infect Immun | 1996 | https://conductscience.org/library/papers/8751911 | PubMed |
| 8335342 | Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. | Infect Immun | 1993 | https://conductscience.org/library/papers/8335342 | PubMed |
| 8039898 | Peptidoglycan fragments decrease food intake and body weight gain in rats. | Infect Immun | 1994 | https://conductscience.org/library/papers/8039898 | PubMed |
| 7506415 | Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7506415 | PubMed |
| 7500012 | Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. | J Exp Med | 1995 | https://conductscience.org/library/papers/7500012 | PubMed |
| 7420023 | Central pyrogenic activity of muramyl dipeptide. | J Exp Med | 1980 | https://conductscience.org/library/papers/7420023 | PubMed |
| 7216446 | Endogenous pyrogen production by human blood monocytes stimulated by staphylococcal cell wall components. | Infect Immun | 1981 | https://conductscience.org/library/papers/7216446 | PubMed |
| 7035868 | Muramyl peptides. Chemical structure, biological activity and mechanism of action. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/7035868 | PubMed |
| 7035362 | Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. | Infect Immun | 1982 | https://conductscience.org/library/papers/7035362 | PubMed |
| 7019079 | Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice. | Infect Immun | 1981 | https://conductscience.org/library/papers/7019079 | PubMed |
| 6835353 | Immunostimulation with muramyl dipeptide and its desmethyl analogue: Studies of non-specific resistance to pulmonary blastomycosis in inbred mouse strains. | Mycopathologia | 1983 | https://conductscience.org/library/papers/6835353 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/368262
GET https://conductscience.org/api/papers/v1/368262/cited_by?page=2